BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15726024)

  • 1. Ziprasidone-induced galactorrhea: a case report.
    Kopecek M; Bares M; Mohr P
    Neuro Endocrinol Lett; 2005 Feb; 26(1):69-70. PubMed ID: 15726024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D2-blockade and possible ziprasidone-induced galactorrhea.
    Ramadan M; Khan A; Preskorn S
    Int Clin Psychopharmacol; 2005 Mar; 20(2):113-4. PubMed ID: 15729088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
    Borovicka MC; Bond LC; Gaughan KM
    Ann Pharmacother; 2006 Jan; 40(1):139-42. PubMed ID: 16352776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ziprasidone-associated galactorrhea in a female teenager.
    Jordan MP
    J Am Acad Child Adolesc Psychiatry; 2003 Jan; 42(1):4-5. PubMed ID: 12500070
    [No Abstract]   [Full Text] [Related]  

  • 5. Ziprasidone-associated pedal edema in the treatment of schizophrenia.
    Ku HL; Su TP; Chou YH
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):963-4. PubMed ID: 16624468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ziprasidone-related oculogyric crisis in an adult.
    Viana Bde M; Prais HA; Camargos ST; Cardoso FE
    Clin Neurol Neurosurg; 2009 Dec; 111(10):883-5. PubMed ID: 19717224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ziprasidone induced tardive cervical dystonia.
    Kutlu A; Dündar S; Altun NS; Budak F
    Psychopharmacol Bull; 2009; 42(4):64-8. PubMed ID: 20581794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ziprasidone-induced tardive laryngeal dystonia: a case report.
    Tsai CS; Lee Y; Chang YY; Lin PY
    Gen Hosp Psychiatry; 2008; 30(3):277-9. PubMed ID: 18433661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ziprasidone-associated depressive state in schizophrenic patients.
    Kaptsan A; Dwolatzky T; Lerner V
    Clin Neuropharmacol; 2007; 30(6):357-61. PubMed ID: 18090461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of the electroconvulsive therapy-ziprasidone combination.
    Masdrakis VG; Florakis A; Tzanoulinos G; Markatou M; Oulis P
    J ECT; 2010 Jun; 26(2):139-42. PubMed ID: 20386116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
    Ozen ME; Yumru M; Savas HA; Cansel N; Herken H
    World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endocrine side effects among psychiatric patients treated with antipsychotics].
    Kovács L; Kovács G
    Neuropsychopharmacol Hung; 2006 Jun; 8(2):61-6. PubMed ID: 17073213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ziprasidone-associated galactorrhea in an adolescent female.
    Saldaña SN; Delgado SV
    J Child Adolesc Psychopharmacol; 2007 Apr; 17(2):259-60. PubMed ID: 17489723
    [No Abstract]   [Full Text] [Related]  

  • 14. Naturalistic study of intramuscular ziprasidone versus conventional agents in agitated elderly patients: retrospective findings from a psychiatric emergency service.
    Kohen I; Preval H; Southard R; Francis A
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):240-5. PubMed ID: 16503319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute dystonia after initial doses of ziprasidone: a case report.
    Yumru M; Savas HA; Selek S; Savas E
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):745-7. PubMed ID: 16580766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ziprasidone as a possible cause of cleft palate in a newborn.
    Peitl MV; Petrić D; Peitl V
    Psychiatr Danub; 2010 Mar; 22(1):117-9. PubMed ID: 20305605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose ziprasidone-induced acute dystonia.
    Rosenfield PJ; Girgis RR; Gil R
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):546-7. PubMed ID: 17123682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
    Zink M; Kuwilsky A; Krumm B; Dressing H
    J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ziprasidone and the QTc interval: pharmacokinetic and pharmacodynamic considerations.
    Kelly DL; Love RC
    Psychopharmacol Bull; 2001; 35(4):66-79. PubMed ID: 12397857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of severe hyponatremia induced by duloxetine and ziprasidone.
    Li RM; Wang C; Liu ZW; Zhao B
    Chin Med J (Engl); 2012 Oct; 125(20):3750-1. PubMed ID: 23075738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.